146
Participants
Start Date
November 15, 2019
Primary Completion Date
September 2, 2022
Study Completion Date
September 26, 2022
Oltipraz
Total 90mg, By mouth, TID
Placebos
Total 90mg, By mouth, TID
Dong-A University Hospital, Busan
Inje University Ilsan Paik Hospital, Goyang-si
The Catholic University of Korea, Uijeongbu ST. Mary's Hospital, Uijeongbu-si
Inha University Hospital, Incheon
Catholic University Bucheon ST. Mary's Hospital, Bucheon-si
Soonchunhyang University Bucheon Hospital, Bucheon-si
Keimyung University Dongsan Medical Center, Daegu
Gangneung Asan Medical Center, Gangneung-si
Chung-Ang University Hosptial, Seoul
Hallym University Gangnam Sungsim Hospital, Seoul
Hanyang University Hospital, Seoul
Korea University Guro Hospital, Seoul
National Medical Center, Seoul
Severance Hospital, Seoul
Soonchunhyang University Seoul Hospital, Seoul
Yonsei University Gangnam Severance Hospital, Seoul
Ajou University School of Medicine, Suwon
Wonju Severance Christian Hospital, Wanju
NHUS Ilsan Hospital, Goyang-si
Seoul National University Hospital, Seoul
Boramae Hospital, Seoul
Lead Sponsor
PharmaKing
INDUSTRY